Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhongyuan Union Stem Cell Bioengineering Co appoints chairman and general manager

Friday, 7 Feb 2014 07:00pm EST 

Zhongyuan Union Stem Cell Bioengineering Co:Appoints Li Defu as chairman of the board and Wu Mingyuan as general manager of the company, effective Feb. 8. 

Company Quote